Literature DB >> 11271788

Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma.

M J Pukkila1, J A Virtaniemi, E J Kumpulainen, R T Pirinen, R T Johansson, H J Valtonen, M T Juhola, V M Kosma.   

Abstract

AIMS: To investigate the expression of alpha, beta, and gamma catenins in oropharyngeal and hypopharyngeal squamous cell carcinoma and their relations to each other, as well as to clinical data, tumour differentiation, and prognosis.
METHODS: Primary tumours for analysis were obtained from 138 patients diagnosed with squamous cell carcinoma of the oropharynx or hypopharynx between 1975 and 1998 in eastern Finland. Immunohistochemistry was used to evaluate the expression of alpha, beta, and gamma catenins. The expression patterns of all catenins were related to clinical data and survival.
RESULTS: The expression patterns of all three catenins were significantly interrelated. Reduced gamma catenin expression was significantly associated with poor histological differentiation. No association was found between alpha or beta catenin expression and clinicopathological characteristics. In univariate analysis, patients whose tumours had nuclear beta catenin expression had shorter overall survival than patients with no nuclear expression. In Cox multivariate analysis, nuclear beta catenin expression, tumour status (T class), and Karnofsky performance index were independent prognostic factors of overall survival.
CONCLUSIONS: Reduced expression of gamma catenin is associated with dedifferentiation in primary squamous cell carcinoma of the oropharynx and hypopharynx. The fact that nuclear beta catenin expression independently predicts short overall survival suggests that it might be a valuable prognostic marker in pharyngeal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11271788      PMCID: PMC1731271          DOI: 10.1136/jcp.54.1.42

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  40 in total

1.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

Review 2.  Cytoskeleton-membrane interactions.

Authors:  P Cowin; B Burke
Journal:  Curr Opin Cell Biol       Date:  1996-02       Impact factor: 8.382

3.  Functional interaction of beta-catenin with the transcription factor LEF-1.

Authors:  J Behrens; J P von Kries; M Kühl; L Bruhn; D Wedlich; R Grosschedl; W Birchmeier
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

Review 4.  Signal transduction through beta-catenin and specification of cell fate during embryogenesis.

Authors:  J R Miller; R T Moon
Journal:  Genes Dev       Date:  1996-10-15       Impact factor: 11.361

5.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

6.  Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.

Authors:  A Jawhari; S Jordan; S Poole; P Browne; M Pignatelli; M J Farthing
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

Review 7.  Cadherin-catenin complex: protein interactions and their implications for cadherin function.

Authors:  H Aberle; H Schwartz; R Kemler
Journal:  J Cell Biochem       Date:  1996-06-15       Impact factor: 4.429

8.  Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck.

Authors:  G L Bowie; A W Caslin; N J Roland; J K Field; A S Jones; A R Kinsella
Journal:  Clin Otolaryngol Allied Sci       Date:  1993-06

9.  E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck.

Authors:  J H Schipper; A Unger; K Jahnke
Journal:  Clin Otolaryngol Allied Sci       Date:  1994-10

10.  Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor.

Authors:  H Hoschuetzky; H Aberle; R Kemler
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  11 in total

1.  Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.

Authors:  R T Pirinen; P Hirvikoski; R T Johansson; S Hollmén; V M Kosma
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

2.  Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.

Authors:  F Böhrnsen; M Fricke; C Sander; A Leha; H Schliephake; F J Kramer
Journal:  Clin Oral Investig       Date:  2014-10-28       Impact factor: 3.573

3.  The role of E-cadherin/beta-catenin complex and cyclin D1 in head and neck squamous cell carcinoma.

Authors:  Nam Yong Do; Sung Yong Park; Sung Chul Lim
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

4.  Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.

Authors:  Chien-Hsing Lee; Hsing-Wen Hung; Pei-Hsin Hung; Yi-Shing Shieh
Journal:  Mol Cancer       Date:  2010-03-19       Impact factor: 27.401

5.  Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study.

Authors:  M J Pukkila; A S T Kosunen; J A Virtaniemi; E J Kumpulainen; R T Johansson; J K Kellokoski; J Nuutinen; V-M Kosma
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

Review 6.  acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx.

Authors:  T R Helliwell
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

7.  Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer.

Authors:  Eun-Jin Yeo; Luca Cassetta; Bin-Zhi Qian; Ian Lewkowich; Jiu-feng Li; James A Stefater; April N Smith; Lisa S Wiechmann; Yihong Wang; Jeffrey W Pollard; Richard A Lang
Journal:  Cancer Res       Date:  2014-03-17       Impact factor: 12.701

8.  Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression.

Authors:  Anna Jouppila-Mättö; Mervi Närkiö-Mäkelä; Ylermi Soini; Matti Pukkila; Reijo Sironen; Hanna Tuhkanen; Arto Mannermaa; Veli-Matti Kosma
Journal:  BMC Cancer       Date:  2011-08-11       Impact factor: 4.430

9.  Prognostic significance of E-Cadherin, β-Catenin and cyclin D1 in oral squamous cell carcinoma: a tissue microarray study.

Authors:  Natheer Al-Rawi; Muwaffaq Al Ani; Asif Quadri; Zaid Hamdoon; Aktham Awwad; Sausan Al Kawas; Ahmed Al Nuaimi
Journal:  Histol Histopathol       Date:  2021-07-26       Impact factor: 2.303

10.  Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck.

Authors:  P Mhawech; P Dulguerov; E Tschanz; C Verdan; C Ares; A S Allal
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.